Start of main content

Why we need engineers in vaccine manufacturing?


If we ask you who makes vaccines what would you answer? Most answers would include Scientists (people in white coats working in research labs), clinicians, clinical trial volunteers and even financiers. Very few people ever include engineers. But think about that for a moment. Yes, a vaccine is discovered in the lab and used in the clinic. But for it to be useful to society it must be manufactured at large scale and at an affordable cost and able to be distributed wherever is needed. The most effective vaccine is of no use if this cannot be done. This is where engineers (Biochemical engineers), scientists, clinicians and policy makers must work together to take vaccines from the laboratory through large scale manufacture, and out to real world practical use.


Continuing Professional Development

This event can contribute towards your Continuing Professional Development (CPD) hours as part of the IET's CPD monitoring scheme.

Clock icon

12 Jun 2024 

6:00pm - 9:00pm

Clock icon


  • London Local Network

Registration information

Please register to attend

Free of charge


Dr Stephen A Morris

VaxHub Outreach & Public Engagement Manager - UCL

I studied Microbiology (B.Sc Hons, Cardiff) and Biophysics (Ph.D Kings College London).

During my career started in biochemistry/cell biology, working for many years on multi-protein complexes, intracellular trafficking machinery and ion channels. This led to my interest in the cell biology of viruses and the generation of new vaccines.

I have worked in academic institutions in the UK, Germany and USA, and spent a number of years developing VLP based vaccines in the UK Biotech Industry.

I am now part of the UCL Vaccine Manufacturing Research Hubs (VaxHub). Initially as Research Fellow specialising in the use of high throughout methodologies for vaccine bioprocess development and analytics. With an emphasis on the transfer of these technologies for use in Low to Middle Income Countries (LMIC).

My teaching activities include lecturing to B.Sc, B.Eng, M,Sc and M.Eng students on Vaccine Bioprocessing. In 2022 I started the VaxHub Schools Outreach program. 

Since February 2024 I hold the position of VaxHub Outreach and Public Engagement Manager and Lecturer.

Anca Tacu

Policy Advisor - UCL

Anca Tacu is a Policy Adviser in UCL Engineering’s Policy Impact Unit. She is currently working closely with researchers at the Manufacturing Research Hub for a Sustainable Future (Vax-Hub Sustainable) and the Vaccines Manufacturing Hub for LMICs (Vax-Hub Global) to facilitate and enhance the policy impact of their work.

Anca has previously held roles in UCL in the Institute for Innovation and Public Purpose (IIPP) and School of Pharmacy, which included managing and developing the growing collaboration with New Giza University to support undergraduate education in Egypt. Anca’s background includes a particular emphasis on the Sustainable Development Goals (SDGs). She was the founding network manager of the Sustainable Development Solutions Network UK, growing this into a thriving collaborative space for UK HEIs to contribute actionable research to policy making. Anca’s work at IIPP was within an innovation research/policy interaction space and included the Biscay Fiscal Policy and the SDGs project, the SDG data gaps project in collaboration with the Office for National Statistics (ONS), and work towards the post-2030 Agenda.

Dr. Salomé Sá Magalhães

Research Fellow - UCL Department of Biochemical Engineering

Since joining UCL in 2019, Salomé has gained expertise in addressing key challenges in the scale-up and optimisation of vaccine bioprocessing. This has complemented her previous experience from her PhD at IST (Portugal) and Nofima (Norway), focusing on the development of new strategies to improve DNA vaccine resistance to nucleases. Including the use of marine resources as DNAse inhibitors. Furthermore, as Head of Biology (Orphidia), Salomé also has experience in developing point-of-care diagnostics. 

Currently her research interests focus on strategies for simplified process development and quality control to accelerate vaccines to market, namely by introducing versatile and continuous platform processes.

Reasons to attend

Understand how engineers play a key role in vaccine production.

Network with other professionals.

Earn CPD points.


IET London: Savoy Place

2 Savoy Place

United Kingdom

The London headquarters of the IET.

We are committed to having an environmentally responsible event portfolio and we are working hard to plan and implement events which reflect sustainable event best practices.

We are working with venues and suppliers that demonstrate best environmental practices, in particular achieving zero food waste, no single-use plastics, along with recycling and re-use of paper, metal, plastic and glass.

In order to reduce the carbon footprint of the event, we strongly encourage delegates to walk, cycle or use public transport to attend the event.

We’re fully committed to reducing our impact on the environment and are constantly looking for ways to become more sustainable.


18:00 - Arrival and registration (Tea/Coffee/Sandwiches)

18:30 - Lecture begins

19:30 - Q&A

20:00 - Networking reception (CashBar, Tea/Coffee/Sandwiches)

21:00 - Close



Please register to attend

Free of charge